PUBLISHER: TechNavio | PRODUCT CODE: 1916078
PUBLISHER: TechNavio | PRODUCT CODE: 1916078
Global Ct And Ng Testing Market 2025-2029
The global ct and ng testing market is forecasted to grow by USD 883.4 mn during 2024-2029, accelerating at a CAGR of 8.4% during the forecast period. The report on the global ct and ng testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of ct and ng infections, advancements in molecular diagnostic technologies, increasing focus on point of care testing.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 7.9% |
| CAGR | 8.4% |
| Incremental Value | $883.4 mn |
Technavio's global ct and ng testing market is segmented as below:
By Product
- Assays and kits
- Instruments and analyzers
By Test
- Lab tests
- PoC tests
By End-User
- Diagnostic laboratories
- Hospitals and clinics
- Public health agencies and NGOs
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Russia
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the expansion of point-of-care molecular diagnostics as one of the prime reasons driving the global ct and ng testing market growth during the next few years. Also, integration of digital health and telemedicine with testing services and rise of multiplex and comprehensive sti panels will lead to sizable demand in the market.
The report on the global ct and ng testing market covers the following areas:
- Global ct and ng testing market sizing
- Global ct and ng testing market forecast
- Global ct and ng testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global ct and ng testing market vendors that include Abbott Laboratories, Aptitude Medical Systems Inc., Becton Dickinson and Co., binx health Inc., Bio Rad Laboratories Inc., Cepheid Inc., DiaSorin SpA, ELITechGroup SAS, F. Hoffmann La Roche Ltd., GeneProof, Hologic Inc., LetsGetChecked, Meridian Bioscience Inc., Promega Corp., QIAGEN N.V., Seegene Inc., Thermo Fisher Scientific Inc., VIRCELL S.L., Visby Medical Inc.. Also, the global ct and ng testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Test
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
5 Historic Market Size
- 5.1 Global Ct And Ng Testing Market 2019 - 2023
- Historic Market Size - Data Table on Global Ct And Ng Testing Market 2019 - 2023 ($ million)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
- 5.3 Test segment analysis 2019 - 2023
- Historic Market Size - Test Segment 2019 - 2023 ($ million)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global Ct and Ng testing market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
8 Market Segmentation by Product
- 8.1 Market segments
- 8.2 Comparison by Product
- 8.3 Assays and kits - Market size and forecast 2024-2029
- 8.4 Instruments and analyzers - Market size and forecast 2024-2029
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
9 Market Segmentation by Test
- 9.1 Market segments
- 9.2 Comparison by Test
- 9.3 Lab tests - Market size and forecast 2024-2029
- 9.4 PoC tests - Market size and forecast 2024-2029
- 9.5 Market opportunity by Test
- Market opportunity by Test ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Diagnostic laboratories - Market size and forecast 2024-2029
- 10.4 Hospitals and clinics - Market size and forecast 2024-2029
- 10.5 Public health agencies and NGOs - Market size and forecast 2024-2029
- 10.6 Others - Market size and forecast 2024-2029
- 10.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- 12.3.1 US - Market size and forecast 2024-2029
- 12.3.2 Canada - Market size and forecast 2024-2029
- 12.3.3 Mexico - Market size and forecast 2024-2029
- 12.4 Europe - Market size and forecast 2024-2029
- 12.4.1 Germany - Market size and forecast 2024-2029
- 12.4.2 UK - Market size and forecast 2024-2029
- 12.4.3 France - Market size and forecast 2024-2029
- 12.4.4 Italy - Market size and forecast 2024-2029
- 12.4.5 The Netherlands - Market size and forecast 2024-2029
- 12.4.6 Spain - Market size and forecast 2024-2029
- 12.4.7 Russia - Market size and forecast 2024-2029
- 12.5 Asia - Market size and forecast 2024-2029
- 12.5.1 China - Market size and forecast 2024-2029
- 12.5.2 Japan - Market size and forecast 2024-2029
- 12.5.3 India - Market size and forecast 2024-2029
- 12.5.4 South Korea - Market size and forecast 2024-2029
- 12.5.5 Indonesia - Market size and forecast 2024-2029
- 12.5.6 Thailand - Market size and forecast 2024-2029
- 12.5.7 Singapore - Market size and forecast 2024-2029
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- 12.6.1 Australia - Market size and forecast 2024-2029
- 12.6.2 UAE - Market size and forecast 2024-2029
- 12.6.3 Brazil - Market size and forecast 2024-2029
- 12.6.4 South Africa - Market size and forecast 2024-2029
- 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
- 12.6.6 Turkey - Market size and forecast 2024-2029
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing prevalence of Ct and Ng infections
- Advancements in molecular diagnostic technologies
- Increasing focus on point of care testing
- 13.2 Market challenges
- Lack of awareness and stigma
- High cost of advanced diagnostic tests
- Antimicrobial resistance
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Expansion of point-of-care molecular diagnostics
- Integration of digital health and telemedicine with testing services
- Rise of multiplex and comprehensive STI panels
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 15.6 binx health Inc.
- binx health Inc. - Overview
- binx health Inc. - Product / Service
- binx health Inc. - Key offerings
- SWOT
- 15.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.8 Cepheid Inc.
- Cepheid Inc. - Overview
- Cepheid Inc. - Product / Service
- Cepheid Inc. - Key offerings
- SWOT
- 15.9 DiaSorin SpA
- DiaSorin SpA - Overview
- DiaSorin SpA - Business segments
- DiaSorin SpA - Key news
- DiaSorin SpA - Key offerings
- DiaSorin SpA - Segment focus
- SWOT
- 15.10 ELITechGroup SAS
- ELITechGroup SAS - Overview
- ELITechGroup SAS - Product / Service
- ELITechGroup SAS - Key offerings
- SWOT
- 15.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.12 Hologic Inc.
- Hologic Inc. - Overview
- Hologic Inc. - Business segments
- Hologic Inc. - Key news
- Hologic Inc. - Key offerings
- Hologic Inc. - Segment focus
- SWOT
- 15.13 Meridian Bioscience Inc.
- Meridian Bioscience Inc. - Overview
- Meridian Bioscience Inc. - Product / Service
- Meridian Bioscience Inc. - Key offerings
- SWOT
- 15.14 Promega Corp.
- Promega Corp. - Overview
- Promega Corp. - Product / Service
- Promega Corp. - Key offerings
- SWOT
- 15.15 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key news
- QIAGEN N.V. - Key offerings
- SWOT
- 15.16 Seegene Inc.
- Seegene Inc. - Overview
- Seegene Inc. - Product / Service
- Seegene Inc. - Key offerings
- SWOT
- 15.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
- 15.18 Visby Medical Inc.
- Visby Medical Inc. - Overview
- Visby Medical Inc. - Product / Service
- Visby Medical Inc. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
